ASPIRAPATH (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE/ICCL announces the settlement schedule for the Offer to Buy through the Acquisition Window under Takeover regulations for Aspira Pathlab … | |||||||||||||||
BSE/ICCL announces the settlement schedule for the Offer to Buy through the Acquisition Window under Takeover regulations for Aspira Pathlab & Diagnostics Limited.
| |||||||||||||||
An open offer is made by five acquirers and a PAC to public shareholders of Aspira Pathlab & Diagnostics Limited at Rs. 55 per share to … | |||||||||||||||
An open offer is made by five acquirers and a PAC to public shareholders of Aspira Pathlab & Diagnostics Limited at Rs. 55 per share to acquire up to 26,76,180 equity shares (26% of total voting share capital), open from April 15 to April 28, 2026.
| |||||||||||||||
List of securities and quantities under demat auction for BSE settlement number 767 dated December 2, 2025. | |||||||||||||||
List of securities and quantities under demat auction for BSE settlement number 767 dated December 2, 2025. | |||||||||||||||